Recent news on Copaxone

Charlotte: Chevrolet NASCAR Truck Race Preview  -  25 May 2007
PaddockTalk51 Team COPAXONE® (glatiramer acetate injection) Silverado at Mansfield and to have the opportunity to work with Billy Ballew Motorsports.

Teva may face generic rival to Copaxone  -  May 20, 2007
MarketWatchNatco Pharma Ltd. of Hyderabad, India, said it would launch glatiramer acetate, the generic version of Copaxone, at about 40% of the price of the branded

Treatment with Copaxone Plus Minocycline Showed Substantial ...  -  May 4, 2007
PharmaLive.com (press release),Additionally, the nine-month study demonstrated that treatment with COPAXONE(R) in combination with minocycline reduced the number of new T2 lesions in

Treatment with COPAXONE(R) Plus Minocycline Showed Substantial ...  -  May 4, 2007
Genetic Engineering News (press release),New data from a randomized, double-blind study showed that a combination of COPAXONE(R) (glatiramer acetate injection) along with the oral antibiotic

COPAXONE ® Treatment over Two Years after Short Term Induction ...  -  May 4, 2007
Business Wire (press release),Treatment with COPAXONE ® after induction with mitoxantrone remained safe and effective throughout the treatment period. These new findings were presented

Treatment with Copaxone Plus Minocycline Showed Substantial ...  -  May 4, 2007
PharmaLive.com (press release),KANSAS CITY, Mo, May 4, 2007 - New data from a randomized, double-blind study showed that a combination of Copaxone (glatiramer acetate injection) along

Copaxone sales soar as Teva enjoys earnings growth  -  May 3, 2007
Pharma Times (subscription),Group turnover was up 24% to $2.08 billion, with Copaxone (glatiramer acetate) bringing in $401 million, an increase of 22%, thanks to 18% growth in US

Wed: Teva just keeps going  -  May 14, 2007
Globes,Copaxone sales were continuing to climb steadily every month despite the fears that Tysabri could make it redundant, including during the six months in

Teva Reports First Quarter 2007 Results  -  May 2, 2007
Genetic Engineering News (press release),Strong demand for our generics products across all our geographies, along with record-breaking quarterly sales of Copaxone(R), and the continued rapid

Sutton's Return Helps Make History  -  Apr 26, 2007
TruckSeries.com,51 Team COPAXONE® (glatiramer acetate injection) Chevrolet Silverado NASCAR Craftsman Truck for the running of the O’Reilly Auto Parts 250.

Friday's Health Winners & Losers  -  May 4, 2007
TheStreet.comThe company announced that new data showed patients with multiple sclerosis who were treated with Copaxone following chemotherapy-drug Mitoxantrone showed

Further research different phases local health kits.  -  Apr 26, 2007
Journal lycéen,Biologic potential doctor stress Copaxone evaluatio lung stringers. Various antiviral surgical site Phenazopyridine limb and Aromasin early.

Kansas Features Familiar Faces  -  Apr 25, 2007
PaddockTalk51 Team Copaxone Chevrolet). Sutton has been a series regular since making her debut in 2003. Sutton holds the record for most starts (51) and most winnings

Teva Provides Update on Generic Lotrel Litigation  -  May 21, 2007
PharmaLive.com (press release),...especially Copaxone(R) sales, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry,

Natco Pharma fortifies its presence in Neurology segment, launches ...  -  May 16, 2007
Equity Bulls,The branded version - called Copaxone - has a global sales of US $ 1.8 Billion. Incidental Glatimer will be a peptide chemistry based product - the first

In A Market Of Injectables, Differences In Convenience Can Greatly ...  -  May 9, 2007
eMaxHealth.com,Bayer Healthcare Pharmaceuticals' Betaseron, Teva's Copaxone), which use smaller, less burdensome needles than Biogen Idec's Avonex's intramuscular

Sutton's Return Helps Make History  -  26 Apr 2007
TruckSeries.com,51 Team COPAXONE® (glatiramer acetate injection) Chevrolet Silverado NASCAR Craftsman Truck for the running of the O’Reilly Auto Parts 250.

Kansas: Chevy NASCAR Truck Race Preview  -  26 Apr 2007
PaddockTalk..."I am also very grateful to Team COPAXONE® (glatiramer acetate injection) for giving me the opportunity to conqueror the track that took so much away from

Data on Higher Dose of Copaxone and Data Showing Copaxone is Most ...  -  Apr 17, 2007
PharmaLive.com (press release),In addition, patients taking COPAXONE 40 mg experienced a reduced mean on-trial relapse rate of 77 percent when compared to annual relapse rate prior to

Data Published in Neurology Showed That Higher Dose of COPAXONE(R ...  -  Apr 17, 2007
Genetic Engineering News (press release),A 9-month, randomized, double-blind, parallel-group Phase II study of 90 patients comparing a 40 mg dose of COPAXONE(R) given daily to the currently

Teva Cites Positive Copaxone Data  -  Apr 17, 2007
Forbes,The Phase II clinical trial showed a 40-milligram dose of Copaxone delivered a 38 percent greater reduction in inflammatory disease activity compared with

First Pharmacoeconomic Analysis with Long-Term Data Showed ...  -  Apr 11, 2007
Business Wire (press release),Findings of this study indicated that of the four therapies used to manage MS and in comparison with symptom management alone, the use of COPAXONE ® was the

Teva (TEVA) Reports Long-Term Data Showed COPAXONE(R) Was More ...  -  Apr 11, 2007
StreetInsider.com (subscription),...alone revealed that Teva's (Nasdaq: TEVA) COPAXONE was the most cost-effective treatment strategy for relapsing-remitting multiple sclerosis (RRMS).

Ballew & Sutton Ink Four-Race Deal with Team COPAXONE Sponsor  -  Mar 31, 2007
TruckSeries.com,51 Team COPAXONE (glatiramer acetate injection) Chevrolet Silverado beginning at the Kansas Speedway NASCAR Craftsman Truck Series event, the O'Reilly Auto

Market Report -- In Play (TEVA)  -  Apr 17, 2007
MSN MoneyTeva Pharm says data published in neurology showed that higher dose of Copaxone increased efficacy in RRMS TEVA announces a 9-month, randomized,

MS Walk to raise money for research for Multiple Sclerosis  -  Apr 12, 2007
Zanesville Times Recorder,Since her diagnosis she's been on four different types of drugs that are used to treat MS and has found that Copaxone works best for her.

MEDICAL AND FITNESS NEWS  -  Apr 14, 2007
Chattanooganow (subscription),And Betaseron, Avonex, Rebif and Copaxone -- medicines most have never heard of -- can provide many MS patients with retention of functions that were

Colgate defender keeps MS at bay  -  Apr 14, 2007
Newsday,Controlling the disease with help from the drug Copaxone that Campaner injects every day, Campaner hopes to land a free-agent contract in the pro ranks next

Sutton set to rejoin Truck Series  -  Mar 31, 2007
ThatsRacin.com51 Team COPAXONE Chevrolet beginning at the Kansas Speedway NASCAR Craftsman Truck Series event, the O’Reilly Auto Parts 250 April 28.

Graduate Programs Quick Links  -  Mar 30, 2007
exduco.net,They will be given either estriol along with Copaxone, an MS drug currently in use, or a placebo along with Copaxone. "That way, no one will receive less

Kelly Sutton Returns to Truck Series  -  Apr 4, 2007
PaddockTalk51 Team Copaxone Chevrolet) suits up at Kansas Speedway for the first of four races on April 28. Sutton has the most starts, 51, and largest winnings,

Sutton to drive 51 truck in four '07 races for Ballew  -  Mar 31, 2007
NascarTeam Copaxone is the primary sponsor of the No. 51 truck and an associate sponsor for the No. 15 truck driven by Lester.

Sutton returning to Craftsman Truck Series  -  Mar 31, 2007
Scene Daily (subscription),She will be bringing sponsorship from Copaxone, a drug for people with multiple sclerosis, which Sutton has. "We're looking for additional sponsors to do

• Stepping into the light  -  Mar 31, 2007
Syracuse Post Standard,At that point his daily dose of Copaxone leaves the syringe and courses through his body, bolstering Campaner's defense against multiple sclerosis.

Chip shots: Local golf results  -  Apr 23, 2007
Marion Chronicle Tribune,The second annual Team Copaxone Fundraising Golf Tournament originally scheduled for Wednesday at Arbor Trace Golf Course has been postponed to later this

MS Patients Not Receiving Medications To Slow Disease Progression ...  -  Apr 20, 2007
Medical News Today (press release),They are: interferon-1b (sold under the name Betaseron®), interferon-1a (Avonex®), glatiramer acetate (GA or Copaxone®), interferon-1a (Rebif®),

Wed: TASE continues mixed  -  Apr 18, 2007
Globes,Teva's flagship product, Copaxone, has continued to demonstrate strong potential, with the company reportedly set to apply to the US Food and Drug

MS patients not receiving medications to slow disease progression  -  Apr 18, 2007
News-Medical.net,They are: interferon-1b (sold under the name Betaseron), interferon-1a (Avonex), glatiramer acetate (GA or Copaxone), interferon-1a (Rebif),

EASTBROOK SPORTS PHYSICALS  -  Apr 18, 2007
Marion Chronicle Tribune,The second annual Team Copaxone Fundraising Golf Tournament is April 25 at Arbor Trace Golf Course. The tournament is designed to raise money for Multiple

No hurdles big enough: Inspiration through wife's disease and ...  -  Apr 17, 2007
Eagle Tribune,Larcome talked to his wife, who for three years has taken a Copaxone shot, which treats MS, every day. Larcome applied for a number at the Boston Marathon

Tour de Kentucky organizers raising money for MS  -  Apr 15, 2007
Ledger Independent,The local MS patient benefits from a drug called Copaxone, a injection a medicine administered daily. Although Gallenstein took the injection for several

MS : Autoimmune disease saps strength, but not spirit, of Severn mom  -  Apr 15, 2007
Annapolis Capital,Mrs. Dodge injects herself in the abdomen each evening with a pre-loaded syringe of Copaxone, a powerful drug that leaves painful welts on her body at each

Rosetta Genomics: Can This Dream Team Woo Wall Street?  -  Apr 5, 2007
Seeking Alpha,Sela also sits on the board at Teva Pharmaceuticals (TEVA), and co-developed that company's multiple sclerosis drug, Copaxone, together with Prof.

Society asks government to ‘hop to it’  -  Apr 4, 2007
St. John's Telegram,He said this province provides coverage of therapies used in the treatment of MS, such as Betaseron, Copaxone, Avonex and Rebif for beneficiaries of the

NASCAR Review  -  Apr 2, 2007
TruckSeries.com,51 Team Copaxone Chevrolet in four races beginning at Kansas. Until this year, at least one female driver had competed in a series race in six consecutive

Teva Partners with Asthma Foundation and NBA to Go Pro for Asthma ...  -  Apr 2, 2007
American Digital Networks (press release),...especially Copaxone(R) sales, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry,

Teva Partners with Asthma Foundation and NBA to Go Pro for Asthma ...  -  Apr 2, 2007
Business Wire (press release),...especially Copaxone® sales, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry,

Kroger 250 NASCAR Craftsman Truck Series Final Notebook  -  Apr 1, 2007
Backstretch Motorsports,51 Team Copaxone Chevrolet in four races beginning at Kansas . Until this year, at least one female driver had competed in a series race in six consecutive

Post-Hoc Data Analyses Published in Annals of Neurology Found ...  -  Feb 27, 2007
Business Wire (press release),BUSINESS WIRE)--Data from the full cohort of the PROMiSE study showed that treatment with COPAXONE ® (glatiramer acetate injection) did not reach a

Post-Hoc Data Analyses Published in Annals of Neurology Found ...  -  Feb 27, 2007
PharmaLive.com (press release),However, post-hoc analyses demonstrated that COPAXONE(R) significantly delayed time to progression of accumulated disability in male patients in the study

Could estriol be the elixir for MS?  -  Mar 23, 2007
PhysOrg.com,They will be given either estriol along with Copaxone, an MS drug currently in use, or a placebo along with Copaxone. "That way, no one will receive less

Teva’s Copaxone delays disability in male MS patients study  -  Feb 27, 2007
Globes,Use of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) Copaxone significantly delays time to progression of accumulated disability caused by

Initial Analysis of the Full Study Cohort Showed Treatment Did Not ...  -  Feb 27, 2007
Insurance News Net,27, 2007--Data from the full cohort of the PROMiSE study showed that treatment with COPAXONE(R) (glatiramer acetate injection) did not reach a significant

Teva Pharmaceutical (TEVA) Says Data Analyses Published in Annals ...  -  Feb 27, 2007
StreetInsider.com (subscription),Data from the full cohort of the PROMiSE study showed that treatment with COPAXONE did not reach a significant effect on the primary endpoint of accumulated

Teva's MS drug fails to slow disability  -  Feb 27, 2007
Jerusalem Post,Teva Pharmaceutical Industries Ltd., the world's biggest maker of generic drugs, said its Copaxone treatment failed to slow disability in multiple sclerosis

Hapoalim raises Teva target price  -  Mar 1, 2007
Globes,Bank Hapoalim says that Teva’s growth engines will be derived from the change in the business model for Copaxone in the US, the company’s foothold in the

Biotech Day in Review: Biotech Takes a 3% Hit  -  Feb 27, 2007
Seeking Alpha,Teva also published data showing that Copaxone, its existing MS drug, was effective in males who have primary progressive multiple sclerosis.

For Durangoan, MS brought grief, wisdom  -  Mar 5, 2007
Durango Herald,Now he swears by the drug, Copaxone - so much that he is now part of "Team Copaxone," a group of athletes who have MS and are sponsored by the drug maker.

KANSAS CITY AREA  -  Feb 28, 2007
Kansas City Star,Copaxone, a treatment for multiple sclerosis that is marketed by Kansas City-based Teva Neuroscience Inc., slowed the progress of the disease,

Teva’s multiple sclerosis treatment shows some promise in study  -  Feb 27, 2007
Kansas City Star,Copaxone, a multiple sclerosis treatment marketed by Kansas City-based Teva Neuroscience Inc., slowed the progress of the disease in a recent study.

Texas hit-maker doesn't let MS slow him down, releases new album  -  Mar 11, 2007
WMC-TV,The 37-year-old Walker was diagnosed with MS in 1996 and takes a daily injection of Copaxone to keep the disease in check. MS occurs when patients' immune

Teva Provides Update on Generic Celebrex ® Litigation  -  Mar 21, 2007
Business Wire (press release),...especially Copaxone ® sales, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry,

An Israeli Biotech Company Plays the Field  -  Mar 13, 2007
BusinessWeekThey include multiple sclerosis drugs Copaxone and Rebif, from Teva and Merck Serono (SRA), respectively; and Doxil, an ovarian cancer drug from Johnson

Teenager with multiple sclerosis maintains active, positive lifestyle  -  Mar 13, 2007
Palm Beach Post,The doctor took her on as a patient and prescribed her Copaxone, which she injects every night before going to sleep.

Teva Receives First US Approval For Generic UNIRETIC(R) Tablets  -  Mar 12, 2007
PipelineReview.com (press release),...including that relating to the generic versions of Allegra®, Neurontin®, Oxycontin® and Zithromax®, the effects of competition on Copaxone® sales,

Vidor graduate doesn’t let MS slow him down  -  Mar 12, 2007
Orange Leader,Walker, 37, was diagnosed with MS in 1996 and takes a daily injection of Copaxone to keep the disease in check. MS occurs when patients’ immune systems go

Texas Hit-Maker Doesn't Let MS Slow Him Down  -  Mar 11, 2007
MyFox Dallas,Walker, 37, was diagnosed with MS in 1996 and takes a daily injection of Copaxone to keep the disease in check. MS occurs when patients' immune systems go

Teva Receives First US Approval for Generic Uniretic® Tablets  -  Mar 9, 2007
Business Wire (press release),...especially Copaxone® sales, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry,

Teva Receives First US Approval for Generic Uniretic Tablets  -  Mar 9, 2007
PharmaLive.com (press release),...especially Copaxone(R) sales, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry,

A closer look at multiple sclerosis  -  Mar 5, 2007
Staten Island Advance,These drugs include Copaxone and beta-interferon. In patients with very severe cases, the use of chemotherapeutic agents may be considered.

Israel stocks struggle back to flat line; Teva lower  -  Feb 28, 2007
MarketWatchThe company said in a statement on Tuesday that a study found that its Copaxone multiple-sclerosis treatment "did not reach a significant effect on the

Tel Aviv stocks steady as US markets plummet  -  Feb 28, 2007
Jerusalem Post,The stock fell $2, or more than 5%, on Wall Street during Tuesday's sharp declines after the company said a study found that its Copaxone multiple-sclerosis

Tuesday's Health Winners & Losers  -  Feb 27, 2007
TheStreet.comDrugmaker Teva Pharmaceutical (TEVA - Cramer's Take - Stockpickr) was lower after a study of the multiple sclerosis drug Copaxone had disappointing results.

Business news in brief  -  Feb 28, 2007
Philadelphia Inquirer,Drugmaker Teva Pharmaceutical Industries Ltd., which has US headquarters in North Wales, said a study showed its Copaxone treatment did not slow disability

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional